Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Controlled, Prospective Trial to Evaluate the Hemostatic Effect of Lyostypt® Versus Surgicel® in Arterial Bypass Anastomosis

NCT00837954 is registered in ClinicalTrials.gov with Aesculap AG as lead sponsor.

NCT NCT00837954
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00837954 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Controlled, Prospective Trial to Evaluate the Hemostatic Effect of Lyostypt® Versus Surgicel® in Arterial Bypass Anastomosis
Lead sponsor
Aesculap AG
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2009
Completion date
April 30, 2010
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemostasis, peripheral vascular diseases